Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 468285, 13 pages
http://dx.doi.org/10.1155/2014/468285
Research Article

The Impact of Staphylococcus aureus-Associated Molecular Patterns on Staphylococcal Superantigen-Induced Toxic Shock Syndrome and Pneumonia

1Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA
2Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
3Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA
4Department of Immunology and Division of Infectious Diseases, Mayo Clinic College of Medicine, 200 First Street, SW, Rochester, MN 55905, USA

Received 30 January 2014; Revised 25 March 2014; Accepted 29 March 2014; Published 12 June 2014

Academic Editor: Ronald Gladue

Copyright © 2014 Ashenafi Y. Tilahun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Kluytmans, A. van Belkum, and H. Verbrugh, “Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks,” Clinical Microbiology Reviews, vol. 10, pp. 505–520, 1997. View at Google Scholar
  2. R. M. Klevens, M. A. Morrison, J. Nadle et al., “Invasive methicillin-resistant Staphylococcus aureus infections in the United States,” The Journal of the American Medical Association, vol. 298, no. 15, pp. 1763–1771, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Otto, “Understanding the epidemic of community-associated MRSA and finding a cure: are we asking the right questions?” Expert Review of Anti-Infective Therapy, vol. 7, no. 2, pp. 141–143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. H. W. Boucher and G. R. Corey, “Epidemiology of methicillin-resistant Staphylococcus aureus,” Clinical Infectious Diseases, vol. 46, supplement 5, pp. S344–S349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. D. Fraser and T. Proft, “The bacterial superantigen and superantigen-like proteins,” Immunological Reviews, vol. 225, no. 1, pp. 226–243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Duffy, V. Rouilly, V. Libri et al., “Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli,” Immunity, vol. 40, no. 3, pp. 436–450, 2014. View at Publisher · View at Google Scholar
  7. E. Lappin and A. J. Ferguson, “Gram-positive toxic shock syndromes,” The Lancet Infectious Diseases, vol. 9, no. 5, pp. 281–290, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. R. Spaulding, W. Salgado-Pabón, P. L. Kohler, A. R. Horswill, D. Y. M. Leung, and P. M. Schlievert, “Staphylococcal and streptococcal superantigen exotoxins,” Clinical Microbiology Reviews, vol. 26, no. 3, pp. 422–447, 2013. View at Publisher · View at Google Scholar
  9. B. Fournier and D. J. Philpott, “Recognition of Staphylococcus aureus by the innate immune system,” Clinical Microbiology Reviews, vol. 18, no. 3, pp. 521–540, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. T. H. Mogensen, “Pathogen recognition and inflammatory signaling in innate immune defenses,” Clinical Microbiology Reviews, vol. 22, no. 2, pp. 240–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. J. de Kimpe, M. Kengatharan, C. Thiemermann, and J. R. Vane, “The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 22, pp. 10359–10363, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. J. S. Cho, E. M. Pietras, N. C. Garcia et al., “IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice,” The Journal of Clinical Investigation, vol. 120, no. 5, pp. 1762–1773, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Reynolds, B. P. Pappu, J. Peng et al., “Toll-like receptor 2 signaling in CD4+ T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease,” Immunity, vol. 32, no. 5, pp. 692–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Khare, A. Dorfleutner, N. B. Bryan et al., “An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages,” Immunity, vol. 36, no. 3, pp. 464–476, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Kapetanovic, M. Parlato, C. Fitting, V. Quesniaux, J.-M. Cavaillon, and M. Adib-Conquy, “Mechanisms of TNF induction by heat-killed Staphylococcus aureus differ upon the origin of mononuclear phagocytes,” The American Journal of Physiology-Cell Physiology, vol. 300, no. 4, pp. C850–C859, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Sethi and T. Chakraborty, “Role of TLR- / NLR-signaling and the associated cytokines involved in recruitment of neutrophils in murine models of Staphylococcus aureus infection,” Virulence, vol. 2, no. 4, pp. 316–328, 2011. View at Google Scholar · View at Scopus
  17. M. Schmaler, N. J. Jann, F. Ferracin, and R. Landmann, “T and B cells are not required for clearing Staphylococcus aureus in systemic infection despite a strong TLR2-ÄìMyD88-dependent T cell activation,” The Journal of Immunology, vol. 186, no. 1, pp. 443–452, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. H. Nyirenda, L. Sanvito, P. J. Darlington et al., “TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function,” The Journal of Immunology, vol. 187, no. 5, pp. 2278–2290, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Tsujimoto, S. Ono, P. A. Efron, P. O. Scumpia, L. L. Moldawer, and H. Mochizuki, “Role of toll-like receptors in the development of sepsis,” Shock, vol. 29, no. 3, pp. 315–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Volz, M. Nega, J. Buschmann et al., “Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals,” The FASEB Journal, vol. 24, no. 10, pp. 4089–4102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. van der Poll and S. M. Opal, “Host-pathogen interactions in sepsis,” The Lancet Infectious Diseases, vol. 8, no. 1, pp. 32–43, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. T. A. Chau, M. L. McCully, W. Brintnell et al., “Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome,” Nature Medicine, vol. 15, no. 6, pp. 641–648, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Frodermann, T. A. Chau, S. Sayedyahossein, J. M. Toth, D. E. Heinrichs, and J. Madrenas, “A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus,” Journal of Infectious Diseases, vol. 204, no. 2, pp. 253–262, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Wang, G. Roderiquez, and M. A. Norcross, “Control of adaptive immune responses by Staphylococcus aureus through IL-10, PD-L1, and TLR2,” Scientific Reports, vol. 2, article 606, 2012. View at Publisher · View at Google Scholar
  25. M. Otto, “Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus,” Annual Review of Microbiology, vol. 64, pp. 143–162, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. L. DaSilva, B. C. Welcher, R. G. Ulrich, M. J. Aman, C. S. David, and S. Bavari, “Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines,” Journal of Infectious Diseases, vol. 185, no. 12, pp. 1754–1760, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Sriskandan, M. Unnikrishnan, T. Krausz et al., “Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice,” Journal of Infectious Diseases, vol. 184, no. 2, pp. 166–173, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. C. J. Roy, K. L. Warfield, B. C. Welcher et al., “Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B,” Infection and Immunity, vol. 73, no. 4, pp. 2452–2460, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. J. Karau, A. Tilahun, S. Schmidt, C. R. Clark, R. Patel, and G. Rajagopalan, “Linezolid is superior to vancomycin in experimental pneumonia caused by superantigen-producing Staphylococcus aureus in HLA class II transgenic mice,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 10, pp. 5401–5405, 2012. View at Publisher · View at Google Scholar
  30. G. Rajagopalan, A. Y. Tilahun, Y. W. Asmann, and C. S. David, “Early gene expression changes induced by the bacterial superantigen, staphylococcal enterotoxin B and its modulation by a proteasome inhibitor,” Physiological Genomics, vol. 37, no. 3, pp. 279–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Rajagopalan, M. K. Smart, C. J. Krco, and C. S. David, “Expression and function of transgenic HLA-DQ molecules and lymphocyte development in mice lacking invariant chain,” The Journal of Immunology, vol. 169, no. 4, pp. 1774–1783, 2002. View at Google Scholar · View at Scopus
  32. A. Y. Tilahun, M. Holz, T.-T. Wu, C. S. David, and G. Rajagopalan, “Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome,” PLoS ONE, vol. 6, no. 2, Article ID e16764, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Wang, X. Meng, J. R. Kuhlman et al., “Knockout of Mkp-1 enhances the host inflammatory responses to gram-positive bacteria,” The Journal of Immunology, vol. 178, no. 8, pp. 5312–5320, 2007. View at Google Scholar · View at Scopus
  34. J. C. Leemans, M. Heikens, K. P. M. van Kessel, S. Florquin, and T. van der Poll, “Lipoteichoic acid and peptidoglycan from Staphylococcus aureus synergistically induce neutrophil influx into the lungs of mice,” Clinical and Diagnostic Laboratory Immunology, vol. 10, no. 5, pp. 950–953, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Y. Tilahun, M. J. Karau, C. R. Clark, R. Patel, and G. Rajagopalan, “The impact of tacrolimus on the immunopathogenesis of staphylococcal enterotoxin-induced systemic inflammatory response syndrome and pneumonia,” Microbes and Infection, vol. 14, no. 6, pp. 528–536, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Schmaler, N. J. Jann, F. Ferracin, and R. Landmann, “T and B cells are not required for clearing Staphylococcus aureus in systemic infection despite a strong TLR2-MyD88-dependent T cell activation,” The Journal of Immunology, vol. 186, no. 1, pp. 443–452, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. D. E. Fry, “Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues,” The American Surgeon, vol. 78, no. 1, pp. 1–8, 2012. View at Google Scholar · View at Scopus
  38. A. Y. Tilahun, E. V. Marietta, T.-T. Wu, R. Patel, C. S. David, and G. Rajagopalan, “Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome,” The American Journal of Pathology, vol. 178, no. 6, pp. 2760–2773, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Silverstein, “D-galactosamine lethality model: scope and limitations,” Journal of Endotoxin Research, vol. 10, no. 3, pp. 147–162, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. M. S. Lee and Y.-J. Kim, “Signaling pathways downstream of pattern-recognition receptors and their cross talk,” Annual Review of Biochemistry, vol. 76, pp. 447–480, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. O. Takeuchi, K. Hoshino, and S. Akira, “Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection,” The Journal of Immunology, vol. 165, no. 10, pp. 5392–5396, 2000. View at Google Scholar · View at Scopus
  42. J. B. Wardenburg, W. A. Williams, and D. Missiakas, “Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 37, pp. 13831–13836, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Sriskandan and D. M. Altmann, “The immunology of sepsis,” Journal of Pathology, vol. 214, no. 2, pp. 211–223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Mangalam, M. Rodriguez, and C. David, “Role of MHC class II expressing CD4+ T cells in proteolipid protein91-110-induced EAE in HLA-DR3 transgenic mice,” European Journal of Immunology, vol. 36, no. 12, pp. 3356–3370, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. P. A. Hopkins, A. C. Pridmore, S. Ellmerich et al., “Increased surface toll-like receptor 2 expression in superantigen shock,” Critical Care Medicine, vol. 36, no. 4, pp. 1267–1276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. S.-S. Kang, H. J. Kim, M. S. Jang et al., “Gene expression profile of human peripheral blood mononuclear cells induced by Staphylococcus aureus lipoteichoic acid,” International Immunopharmacology, vol. 13, no. 4, pp. 454–460, 2012. View at Publisher · View at Google Scholar
  47. S. H. Han, J. H. Kim, M. Martin, S. M. Michalek, and M. H. Nahm, “Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating toll-like receptor 2,” Infection and Immunity, vol. 71, no. 10, pp. 5541–5548, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. N. W. J. Schröder, S. Morath, C. Alexander et al., “Lipoteichoic acid (LTA) of streptococcus pneumoniae and Staphylococcus aureus activates immune cells via toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved,” The Journal of Biological Chemistry, vol. 278, no. 18, pp. 15587–15594, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Wang, F. Li, R. Sun et al., “Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages,” Nature Communications, vol. 4, article 2106, 2013. View at Publisher · View at Google Scholar